Category: us corporate news

us corporate news

Trailblazer Merger Corporation I (TBMC) 2025 Annual Report: Business Strategy, SPAC Merger with Cyabra, and Technology Industry Focus

Minichart

March 10, 2026

Trailblazer Merger Corp I 2025 Annual Report: Key Investor I...

Continue Reading 0

us corporate news

Lipocine Inc. 2025 Annual Report: Innovative Oral Drug Delivery, CNS & Metabolic Pipeline, and R&D Highlights

Minichart

March 10, 2026

Lipocine Inc. 2025 Annual Report: Key Highlights for Investo...

Continue Reading 0

us corporate news

Custom Truck One Source, Inc. 2025 Annual Report: Specialty Equipment Rentals, Sales, and Market Growth Strategies

Minichart

March 10, 2026

Custom Truck One Source, Inc. 2025 Annual Report – Key Insig...

Continue Reading 0

us corporate news

Q32 Bio Inc. 2025 Annual Report: Business Overview, Pipeline, Risks, and Intellectual Property Strategies

Minichart

March 10, 2026

Q32 Bio Inc. 2025 Annual Report: Key Highlights and Investor...

Continue Reading 0

us corporate news

Rapport Therapeutics: Advancing Precision Neuroscience with RAP Technology Platform for Neurological and Psychiatric Disorders 4048

Minichart

March 10, 2026

Rapport Therapeutics 2025 Annual Report: Key Investor Takeaw...

Continue Reading 0

us corporate news

Cullinan Therapeutics 2025 10-K: Advancing First-in-Class Therapies for Autoimmune Diseases and Cancer, Risks, and Strategic Developments

Minichart

March 10, 2026

Cullinan Therapeutics, Inc. 2025 10-K: Key Highlights for In...

Continue Reading 0

us corporate news

Tenax Therapeutics, Inc. 2025 Annual Report: Business Strategy, Risk Factors, Clinical Pipeline, and Regulatory Challenges

Minichart

March 10, 2026

Tenax Therapeutics 2025 Annual Report Analysis Tenax T...

Continue Reading 0

us corporate news

AerSale Corporation Annual Report 2025: Business Overview, Risk Factors, and Growth Strategies

Minichart

March 10, 2026

AerSale Corporation 2025 Annual Report – Key Insights for In...

Continue Reading 0

us corporate news

Protara Therapeutics 2025 Annual Report: Pipeline, Regulatory Strategy, and Commercialization Plans for Cancer and Rare Disease Therapies

Minichart

March 10, 2026

Protara Therapeutics, Inc. 2025 Annual Report: Investor High...

Continue Reading 0

us corporate news

enGene Holdings Inc. Q1 2026 Quarterly Report: Financial Statements, Management Discussion & Key Disclosures

Minichart

March 9, 2026

EnGene Holdings Inc. Q1 2026 Financial Results: Key Details ...

Continue Reading 0